TOKYO -- Drugmaker Daiichi Sankyo is building the first factory in Japan for a homegrown mRNA vaccine against COVID-19, with a planned capacity of 20 million doses a year by fiscal 2024, Nikkei has learned.
COVID vaccines
Japan's 1st plant for mRNA COVID vaccine to be built by Daiichi Sankyo
Drugmaker targets capacity of 20m doses yearly, boosting nation's preparedness
A health care worker administers a vaccine in Osaka. Japan is pivoting away from treating COVID-19 as a health emergency. (Photo by Arisa Moriyama)
Read Next
Latest on COVID vaccines
